Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Inzelberg

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Neurology|January 3, 2001
Transient unilateral mydriasis as the presenting sign of aortic and carotid dissectionR Inzelberg, P Nisipeanu, S C Blumen, et al.
Neurology|October 26, 1999
Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin geneP Nisipeanu, R Inzelberg, S C Blumen, et al.
Neurology|April 23, 2003
Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutationR Inzelberg, N Hattori, P Nisipeanu, et al.
Neurology|September 1, 1996
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuationsR Inzelberg, P Nisipeanu, J M Rabey, et al.
Neurology|October 1, 1993
Genomic imprinting and anticipation in idiopathic torsion dystoniaM C LaBuda, N A Fletcher, A D Korczyn, et al.
Parkinsonism & Related Disorders|January 1, 2015
Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups?Y Orlev, G Yahalom, O S Cohen, et al.
Alzheimer Disease and Associated Disorders|April 16, 1998
Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studiesR Inzelberg, J Chapman, T A Treves, et al.
Neurology|June 13, 2001
Parkin gene causing benign autosomal recessive juvenile parkinsonismP Nisipeanu, R Inzelberg, S Abo Mouch, et al.
Neurology|June 11, 1992
Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutationJ Chapman, P Brown, J M Rabey, et al.
Clinical Neuropharmacology|September 29, 2001
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopaJ M Rabey, I Sagi, M Huberman, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Neurology|January 3, 2001
Transient unilateral mydriasis as the presenting sign of aortic and carotid dissectionR Inzelberg, P Nisipeanu, S C Blumen, et al.
Neurology|October 26, 1999
Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin geneP Nisipeanu, R Inzelberg, S C Blumen, et al.
Neurology|April 23, 2003
Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutationR Inzelberg, N Hattori, P Nisipeanu, et al.
Neurology|September 1, 1996
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuationsR Inzelberg, P Nisipeanu, J M Rabey, et al.
Neurology|October 1, 1993
Genomic imprinting and anticipation in idiopathic torsion dystoniaM C LaBuda, N A Fletcher, A D Korczyn, et al.
Parkinsonism & Related Disorders|January 1, 2015
Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups?Y Orlev, G Yahalom, O S Cohen, et al.
Alzheimer Disease and Associated Disorders|April 16, 1998
Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studiesR Inzelberg, J Chapman, T A Treves, et al.
Neurology|June 13, 2001
Parkin gene causing benign autosomal recessive juvenile parkinsonismP Nisipeanu, R Inzelberg, S Abo Mouch, et al.
Neurology|June 11, 1992
Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutationJ Chapman, P Brown, J M Rabey, et al.
Clinical Neuropharmacology|September 29, 2001
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopaJ M Rabey, I Sagi, M Huberman, et al.
Pageof 6